Business
from24/7 Wall St.
6 days agoNovo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2026-2030 (Dec 2025)
Ozempic-driven weight-loss demand has propelled Novo Nordisk to extraordinary sales and market value, transforming diabetes drugs into highly profitable obesity treatments.